A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Clinical trial NCT04485585 · COMPLETED

Trial details

NCT number: NCT04485585
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)Overactive Bladder

Start date: 2020-07-20
Primary completion: 2020-08-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.